Skip to content

SingStrong: Strong Lungs Through Song - Long COVID-19 Study

SingStrong: Strong Lungs Through Song

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04810065
Acronym
ss
Enrollment
30
Registered
2021-03-22
Start date
2021-03-29
Completion date
2021-09-01
Last updated
2021-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long Covid

Keywords

Singing, Disordered breathing, Covid-19

Brief summary

Evidence is emerging that many individuals who recover from Covid-19 are experiencing a range of residual problems. These include fatigue, pain, reduced exercise tolerance and breathing issues. This study includes participants who are experiencing problems with their lungs such as breathing difficulties, shortness of breath, and/or reduced exercise tolerance. The intervention is a twice weekly singing and breathing retraining intervention conducted over ten weeks. A range of self-report questionnaire measures will evaluate the efficacy of the intervention in addressing these problems. Focus groups and individual interviews will also be used to gather information on the impact and acceptability of the programme.

Interventions

OTHERSingStrong: Strong lungs through Song

Participants who have been clinically diagnosed with Covid-19 and who continue to suffer residual adverse effects on the lung health will be invited to participate in the study. The intervention will involve biweekly hour-long breathing and singing classes that are designed to correct dis-ordered breathing, and retrain the principal muscles of respiration. Pre and post evaluation of participant bio-psychosocial health and wellness will be conducted. Triangulation of data using focus groups and individual interviews will be conducted after conclusion of the intervention,

Sponsors

University of Limerick
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Previous clinical diagnosis of Covid-19 * Ongoing issues with any or all of: Shortness of breath, disordered breathing, reduced exercise tolerance * Good written and spoken English language

Exclusion criteria

* Lack of a confirmed Covid-19 diagnosis * Currently undergoing a similar singing or breathing retraining intervention * No residual problems from a confirmed case of Covid-19

Design outcomes

Primary

MeasureTime frameDescription
Covid-19 Yorkshire Rehab Screen (C19YRS)12 weeksThe C19YRS was developed as a screening tool to monitor long-term symptoms due to Covid-19. The screening tool covers 19 items which combines yes/no answers and an 11 point ordinal scale (0-10) where a higher score denotes increased symptom severity.

Secondary

MeasureTime frameDescription
DePaul Symptom Questionnaire - Short Form DSQ - SF12 weeksThe DPSQ -SF assesses key symptoms of ME/Chronic Fatigue Syndrome such as fatigue, post-exertional malaise, sleep, pain, neurological/cognitive impairments and autonomic, neuroendocrine and immune symptoms. At each item, participants have to rate the frequency and severity of the symptom on a scale from 0 to 4. A higher score denotes increased symptom severity.

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026